Maintenance dosingtypically 0.5 mg weekly for semaglutidepreserves appetite suppression at a reduced cost while allowing your body to stabilize at a new weight
Muscle loss (less discussed): Rapid weight loss without resistance training can lead to muscle mass reduction something your care team should monitor
Key Takeaways Side effects are predictable, dose-dependent, and time-limited for most patients Nausea typically peaks within 48 weeks and improves with body adaptation Each dose escalation produces a temporary, milder return of symptoms Weeks 26 are when most patients quit this is the wrong time to stop Protein, hydration, and resistance training prevent the most common long-term issues (muscle loss, fatigue, constipation) Serious side effects are uncommon but recognisable knowing the warning signs matters If symptoms are unmanageable, ask your prescriber to delay (not skip) a dose escalation References Hawkins-Jarrett ZC, PharmD
The prevalence of HSV and VZV infections is notably higher among diabetic patients compared to the general population, which may be attributed to the immunocompromised state associated with DM [14, 15]
AOD-9604, a fat-targeting peptide, provides a more localized fat-burning solution by mimicking the effects of growth hormone without the associated side effects
